• Skip to content
  • skip to navigation
AstraZeneca logo AstraZeneca logo
AstraZeneca logo AstraZeneca logo
  • What science can do
  • R&D
    • R&D
    • Our approach
    • Transformative science
    • Data science & AI
    • Our technologies
    • Next generation therapeutics
    • Publications
    • R&D strategic centres
  • Our therapy areas
    • All therapy areas
    • Oncology
    • Cardiovascular, Renal and Metabolism
    • Respiratory & Immunology
    • Other disease areas
    • Pipeline
    • All medicines
  • Our company
    • Our company
    • Our strategy
    • Our people
    • Our commitment to patients
    • Leadership team
    • Cambridge
    • Gothenburg
    • Gaithersburg
  • Careers
  • Investors
    • Investor Relations (Global) UK flag
    • Investor Relations (Sweden) Swedish flag
    • Stock Exchange announcements
    • Results and presentations
    • Annual Reports
    • Governance
    • Shareholder information
    • Dividend policy
    • Key facts
    • FAQs
    • Debt Investors
    • ADR Programme
  • Media
    • Press Releases
    • Media centre
    • Articles
    • Image library
    • COVID-19 visual resources
    • Broadcast videos
    • Archive
    • Media contacts
  • Sustainability
    • Sustainability
    • Access to healthcare
    • Environmental protection
    • Ethics and transparency
    • Resources
  • Partnering
    • Partnering with AstraZeneca
    • Our Partnering teams
    • Our areas of partnering interest
    • Why partner with AstraZeneca?
    • Secrets to successful partnering
    • Supplier Information
  • AstraZeneca Websites
  • Global site
  • Our company
  • Our strategy
  • Our people
  • Leadership team

Our people

I’m inspired by the fact that my colleagues and I can make a real difference. Our work brings value to AstraZeneca and our partners and most importantly, can have a positive impact on the lives of patients.

Åsa Sjöholm Timén, PhD, Associate Transaction Director, Business Development Operations

View Åsa's profile

Our people

"AstraZeneca’s entrepreneurial and evidence-based culture encourages us to recognise where successful innovation may require collaborating or licensing. This approach enables us to push the boundaries of science by maximising the utility of our resources, ultimately increasing the benefit to patients".

Associate Transaction Director, Business Development Operations

View Umaima's profile

Our people

"I feel privileged to work with, lead and learn from so many excellent professionals in the areas of science, operations and business, both within AstraZeneca and externally with our partners. Adaptability is a key ability in an environment with an intrinsic level of uncertainty and continued regulatory and legal changes."

Andrea Burgos Prieto, Associate Director Alliance & Integration Management, Business Development Operations

View Andrea's profile

Our people

“Partnering is about bringing together the most talented people with different backgrounds to solve complex tasks, which I find very rewarding. In my role, I am fortunate to experience many different aspects of AstraZeneca’s business and how it all fits together. The energy within these walls is remarkable.”

Fredrik Röök, Transaction Director, Business Development Operations

View Fredrik's profile

Our people

"I believe personalised healthcare is the future of medicine; it allows us to use the latest diagnostic science to target medicines to patients most likely to benefit."

Senior Vice-President of Precision Medicine, R&D Oncology

View Ruth's profile

Alan Sabirsh

Principal Scientist, Advanced Drug Delivery, Pharmaceutical Sciences, R&D

Alicyn Campbell

Head of Digital Health, Oncology R&D

Amy Taylor

Business Planning & Operations Director, Chief Operating Office, BioPharmaceuticals R&D

Anand Subramony

Vice President, Antibody Discovery and Protein Engineering, R&D

Anas Younes

Senior Vice President, Global Head of Haematology (Early and Late Stage) Oncology R&D

Anders Broo

Head of Data Science and Modelling, Pharmaceutical Sciences, R&D

Andrea Burgos Prieto

Associate Director Alliance & Integration Management, Business Development Operations

Andrew Foxley

Vice President, Franchise Head, Late Oncology R&D

Ann E. Taylor

Chief Medical Officer

Anna Sundgren

Global Development Leader, Lokelma & Bydureon

Annette Bak

Head of Advanced Drug Delivery, Pharmaceutical Sciences, R&D

Arpan Desai

Associate Principal Scientist, Advanced Drug Delivery, Pharmaceutical Sciences, R&D

Åsa Sjöholm Timén, PhD

Associate Transaction Director, Business Development Operations

Ashiq Ariff

Data Scientist

Ashling Mulvaney

VP Sustainability, Access to Healthcare & Healthy Heart Africa

Barry Davies

Global Project Leader, Oncology Combinations, Early Oncology

Carlos Doti

Global Medical Affairs Head, Hematology and Ad Interim US Hematology Franchise Head, Medical Affairs

Caroline Germa

Vice President, Head Clinical Development, Early Portfolio, Oncology R&D

Chris Kenny

Senior Information Architect

Christopher J. Rhodes

Chief Scientist, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, and Chair of AstraZeneca’s postdoc programme

Clive Green

Executive Director and Head of Global Sample Management, Discovery Sciences, R&D

Cristian Massacesi

Senior Vice President, Head of Late Stage Development Oncology

Cristina Durán

Chief Digital Health Officer, R&D

Daniel Freeman

Vice President of Early Development Oncology

David Geleta

Data Scientist

David Keeling

Senior Project Leader, Research and Early Development, Respiratory, Inflammation & Autoimmunity, BioPharmaceuticals R&D

Elisa Lázaro Ibáñez

Postdoctoral Researcher, Discovery Biology, Discovery Sciences, R&D

Elisabeth Björk

SVP, Late-Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D

Ella Ekholm

Senior Medical Lead, Late-stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D

Esben Jannik Bjerrum

Principal Scientist, Cheminformatics, Discovery Sciences, R&D

Ezogelin Oflazoglu-Gruyters

Vice-President, Head of External R&D and Strategic Alliances, Oncology R&D

Fredrik Röök

Transaction Director, Business Development Operations

Garry Pairaudeau

Head of Hit Discovery, Discovery Sciences, R&D

Jason Snape

Global Head of Environmental Protection

Jim Weatherall

Vice President, Data Science & AI, R&D

John Houghton

Global Franchise Head, Roxadustat

Joris Silon

Senior Vice President, Global Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals Business Unit

José Baselga

Executive Vice-President, Research & Development Oncology

Kirsha Naicker

Global Study Medical Scientist Leader, Immuno-oncology

Lennart Lindfors

Adjunct Professor and Principal Scientist, Advanced Drug Delivery, Pharmaceutical Sciences, R&D

Li-Ming Gan

Head of Early Clinical Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D

Lutz Jermutus

Head of Projects

Magnus Johansson

Principal Scientist, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D

Malin Lemurell

Senior Director and Head of Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D

Maria Belvisi

Senior Vice President and Head of Research and Early Development, Respiratory, Inflammation and Autoimmunity, BioPharmaceuticals R&D

Maria Groves

Associate Director, Head of the Cancer Research UK – AstraZeneca Antibody Alliance Laboratory (CAZAAL)

Marianne Ashford

Senior Principal Scientist, Advanced Drug Delivery, Pharmaceutical Sciences, R&D

Mark Cobbold

Vice President, Discovery, Oncology R&D

Mark O’Connor

Chief Scientist, Oncology, IMED Biotech Unit

Menelas Pangalos

Executive Vice-President, BioPharmaceuticals R&D

Mika Sovak

Vice President and Franchise Head, R&D, AstraZeneca

Miriam Guest

Associate Principal Scientist, Microbiology, Pharmaceutical Technology and Development

Nicolas Jose Guzman

Director Physician, Nephrology Clinical Research

Ola Engkvist

Associate Director, Computational Chemistry, Discovery Sciences, R&D

Paul Harper

Principal Scientist, Discovery Sciences, R&D

Per Alfredsson

Senior Vice President, Global Biologics Operations

Per Lindblom

Director, Global Project Management

Priti Patel

Vice President, Clinical Development, Haematology

Puja Sapra

Vice President, Tumour Targeted Delivery, Early Oncology

Qing-Dong Wang

Senior Principal Scientist, Bioscience, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D

Ralph Knöll

Chief Scientist, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D

Regina Fritsche-Danielson

SVP, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D

Renee Bailey Iacona

Vice President, Oncology Biometrics, Oncology R&D

Richard Marshall

Senior Vice President and Global Head of Respiratory & Immunology Late Stage Development, BioPharmaceuticals R&D

Ruth March

Senior Vice-President of Precision Medicine, R&D Oncology

Sanya Puri

Associate Director, Advanced Drug Delivery, Pharmaceutical Sciences, R&D

Sara Richardson

New Modality CMC Analytics Team Lead, Advanced Drug Delivery, Pharmaceutical Sciences, R&D

Serban Ghiorghiu

Vice President, Clinical Development, Late Development Oncology R&D

Shawn Davis

Head of Drug Delivery, BioPharmaceuticals Development, R&D

Shin Morita

Vice President, Oncology Business Unit

Simon Bradford

Data & Analytics Enabling Units Engineering Lead

Slavé Petrovski

VP and Head of Genome Analytics & Bioinformatics, Centre for Genomics Research, Discovery Sciences, R&D

Stephen Delaney

Team Leader, Research and Early Development, Respiratory, Inflammation & Autoimmunity (RIA), BioPharmaceuticals R&D

Sunil Verma

Vice President, Global Clinical Head, Breast Cancer and Head of Breast Cancer Research Strategy

Susan Galbraith

Senior Vice President and Head of Research and Early Development, Oncology R&D

Teresa Klinowska

Global Product Leader, AZD9833

Ti Hwei How

Vice President, International Oncology

Tom Keith-Roach

President, AstraZeneca UK

Umaima Ahmad

Associate Transaction Director, Business Development Operations

William Dall’Acqua

Vice President, Antibody Discovery and Protein Engineering, R&D

Regina Fritsche-Danielson

SVP, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D

View Regina's profile

Mark O’Connor

Chief Scientist, Oncology

View Jonathan's profile

Ruth March

Senior Vice-President of Precision Medicine, R&D Oncology

View Ruth's profile

Menelas Pangalos

Executive Vice-President, BioPharmaceuticals R&D

View Menelas's profile

Fredrik Röök

Transaction Director, Business Development Operations

View Fredrik's profile


Our therapy areas

Cardiovascular, Renal and Metabolism

Oncology

Respiratory & Immunology

Neuroscience

Infection and Vaccines


AstraZeneca Websites

This website is intended for people seeking information on AstraZeneca's worldwide business. Our country sites can be located in the AZ Network.




Veeva ID: Z4-25396
Date of next review: August 2022

Resources

  • All resources
  • Open Innovation
  • Externally sponsored scientific research
  • Medical Information for HCPs
  • US prescription assistance programmes
  • Global clinical trials information
  • Medicines
  • Report a possible side effect

Quick links

  • Media
  • Investor Relations
  • Partnering
  • Careers
  • Sustainability
  • Modern Slavery Statement
  • AZethics – Report A Concern
  • Supplier information
  • Social Media Community Guidelines

Social Media

  • LinkedIn
  • Twitter
  • YouTube
  • Instagram
  • Glassdoor
  • Facebook

utility links

  • Legal notice and Terms of Use
  • Privacy notice
  • Site map
  • Contact us
  • Cookie policy

© AstraZeneca 2021

You are now leaving AstraZeneca.com

You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents.

AstraZeneca provides this link as a service to website visitors. AstraZeneca is not responsible for the privacy policy of any third party websites. We encourage you to read the privacy policy of every website you visit.

Click ‘cancel’ to return to AstraZeneca’s site or ‘continue’ to proceed.

Cancel Continue
?

Important notice for users

You are about to access AstraZeneca historic archive material. Any reference in these archives to AstraZeneca products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data or safety data. Please refer to your approved national product label (SmPC) for current product information.

I have read this warning and will not be using any of the contained product information for clinical purposes.

I disagree I agree
?
?